Matching slides 3,571
Current window 2,311-2,340
Pages 120
Rows per page 30
Loop: 21 Before Afterclear collectionreset all

Loop

2,311-2,340 of 3,571

filter-aware
15
The slide highlights the mechanism of action (pH/Ca2+ switch, no effector function, optimal recycling) and the clinical pipeline status for MMN, delayed graft function, and dermatomyositis.argenx SE | Investor Conference Presentation Deck | 22 slides · argenx
Conference presentation Investor relations Beat · New BlissLoop · Before After1 hit
22
The slide uses a standard Kaplan-Meier survival analysis framework common in oncology clinical trials.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
23
Clinical trial data visualization showing hazard ratios and median PFS.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
24
Clinical trial data visualization showing progression-free survival (PFS) curves with associated hazard ratios and event counts.AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
25
The slide uses a split-panel design to compare two patient cohorts (ESR1m detectable vs not detectable).AstraZeneca | Investor Event Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Evidence & ProofLoop · Before After1 hit
25
The slide uses a split-layout with a summary of the partnership on the left and a timeline of expansion on the right.BenevolentAI | Investor Conference Presentation Deck | 29 slides · BenevolentAI
Conference presentation Investor relations Beat · ActionLoop · Before After1 hit
13
The slide validates clinical findings against preclinical models.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · AgitationLoop · Before After1 hit
14
DL = Dose Level; DLT = Dose Limiting Toxicity; SAE = Serious Adverse Event.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · AgitationLoop · Before After1 hit
35
The chart uses a dotted horizontal line to indicate the baseline level of healthy subjects for visual comparison.Kymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
36
Kymera | Results Presentation Deck | 63 slidesKymera | Results Presentation Deck | 63 slides · Kymera
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
29
The slide uses a process flow diagram to show trial progression and a list-based structure for clinical endpoints.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
30
The table displays patient characteristics (age, sex) and disposition (early discontinuation, death, progression) for three distinct dosing groups and the total population.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
31
The chart displays patient outcomes over time, with dots indicating progression and bars indicating stable disease.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
32
Includes a table of adverse events, box plots for cytokines (IL-1b, IL-6, CRP), and a longitudinal line chart for IFNy.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
33
The slide uses a staircase diagram to represent dose escalation levels.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
34
The slide presents a patient cohort table and a specific case study (Patient 6) showing M-spike protein and plasma cell levels over time.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
35
The slide presents clinical trial safety data including a table of adverse events and dot plots for inflammatory markers.Mink Therapeutics | Investor Day Presentation Deck | 92 slides · MiNK Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Before After1 hit
07
Uses a before-after-bridge style framing to demonstrate resilience.Morgan Stanley | Investor Presentation Deck | 27 slides · Morgan Stanley
Conference presentation Investor relations Beat · SolutionLoop · Before After1 hit
16
The chart highlights NYCB's consistently lower non-performing loan ratios compared to the industry index across multiple economic cycles.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
17
The chart uses a dual-bar structure to compare a specific entity against a market benchmark over a long time horizon.New York Community Bancorp | Results Presentation Deck | 26 slides · New York Community Bancorp
Conference presentation Investor relations Beat · FinancialsLoop · Before After1 hit
20
The slide uses a waterfall chart to bridge two financial periods, with a supporting table below detailing the 'What Happened' and 'Actions We Are Taking' for each variance.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
21
USD in millions. Adjusted EBITDA and adjusted EBITDA margin are non-IFRS measures.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
22
The slide uses a waterfall bridge to explain the variance in revenue guidance.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
23
Includes both reported and constant currency revenue projections.Oatly | Results Presentation Deck | 33 slides · Oatly
Conference presentation Investor relations Beat · SatisfactionLoop · Before After1 hit
05
The slide uses a before-after structure to demonstrate business evolution across product offerings, geographic reach, and customer usage patterns.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
06
The slide uses a before-after comparison to demonstrate improved capital efficiency in inventory management.Rent The Runway | Results Presentation Deck | 30 slides · Rent The Runway
Conference presentation Investor relations Beat · Early StrugglesLoop · Before After1 hit
07
Uses a before-after comparison to illustrate the scale of the acquisition.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
08
The table highlights accretion in both Revenue/Share and Adjusted EBITDA/Share.Taboola | Mergers and Acquisitions Presentation Deck | 13 slides · Taboola
Shareholder letter Investment bank Beat · Problem (Identify pain)Loop · Before After1 hit
14
The chart illustrates a worsening of blood pressure in the placebo group compared to the treatment group.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit
15
The slide uses a bar chart with error bars to show treatment effects. 'Worsening' is indicated by a downward arrow on the right.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Before After1 hit